Cushing Syndrome I: Introduction

Cushing syndrome occurs when the body is exposed to excess cortisol, a glucocorticoid hormone, or medications mimicking its effects over a long period. It results from either exogenous causes—prolonged use of corticosteroids like prednisone—or endogenous causes where the body produces excessive cortisol internally. Understanding these distinctions is essential for proper diagnosis and treatment.

ACTH-dependent Cushing syndrome occurs when tumors produce excess ACTH, stimulating cortisol overproduction. This includes Cushing's disease, caused by a pituitary adenoma, and ectopic ACTH secretion from non-pituitary tumors. ACTH-independent causes involve primary adrenal pathology where tumors produce cortisol directly without ACTH stimulation, suppressing pituitary ACTH through negative feedback.

In Cushing's disease, a benign pituitary adenoma secretes excessive ACTH, which overstimulates the adrenal cortex and drives cortisol overproduction. This represents the most common cause of endogenous Cushing syndrome. The elevated cortisol levels persist because the tumor continues producing ACTH autonomously, disrupting normal hormonal regulation.

Adrenal adenomas and carcinomas can synthesize cortisol directly, leading to persistently elevated hormone levels without requiring ACTH stimulation. These ACTH-independent tumors suppress pituitary ACTH through negative feedback. Depending on tumor size and activity, patients exhibit variable degrees of hypercortisolism and cortisol excess.

Ectopic ACTH production occurs when non-pituitary tumors, often located in the lungs or pancreas, produce ACTH autonomously. These tumors secrete ACTH and raise cortisol levels without originating from the normal hypothalamic-pituitary-adrenal axis. This represents an ACTH-dependent mechanism of endogenous Cushing syndrome.

Determining whether cortisol excess is ACTH-dependent or independent guides diagnostic evaluation, imaging studies, hormonal testing, and definitive treatment strategies. This classification helps clinicians identify the underlying pathology—whether a pituitary tumor, adrenal tumor, or ectopic source—enabling targeted therapeutic interventions and improved patient outcomes.

Prolonged therapeutic administration of corticosteroids like prednisone at high doses or for extended durations causes iatrogenic Cushing syndrome. These medications mimic cortisol's effects and suppress the hypothalamic-pituitary-adrenal axis while producing systemic glucocorticoid excess. This represents the most common type of Cushing syndrome overall.